Notre Dame Stories: Developing a COVID-19 Vaccine | News | Notre Dame News | University of Notre Dame Skip To Content Skip To Navigation Skip To Search University of Notre Dame Notre Dame News Experts ND in the News Subscribe About Us Home Contact Search Menu Home › News › Notre Dame Stories: Developing a COVID-19 Vaccine Notre Dame Stories: Developing a COVID-19 Vaccine Published: February 05, 2021 Author: Andy Fuller COVID-19 Vaccine Notre Dame Stories · Developing a COVID-19 Vaccine As most of the country awaits their turn in line to receive a coronavirus vaccine, some have questions about its safety, how it was developed, and what it means for life…after the vaccination. Today we talk with Dr. Mark Mulligan '80, an infectious disease expert and head of NYU’s Langone Vaccine Center. Dr. Mulligan has worked on vaccine trials for decades, including most recently, the vaccine for COVID-19. Notre Dame Stories highlights the work and knowledge of the University's faculty and students. This podcast features interviews with Notre Dame faculty members who can lend insight into some of the major national and international stories of the day, as well as pieces that show the breadth of the life and research at the University. Listen to more episodes here. Posted In: Research Home Experts ND in the News Subscribe About Us Related October 05, 2022 Astrophysicists find evidence for the presence of the first stars October 04, 2022 NIH awards $4 million grant to psychologists researching suicide prevention September 29, 2022 Notre Dame, Ukrainian Catholic University launch three new research grants September 27, 2022 Notre Dame, Trinity College Dublin engineers join to advance novel treatment for cystic fibrosis September 22, 2022 Climate-prepared countries are losing ground, latest ND-GAIN index shows For the Media Contact Office of Public Affairs and Communications Notre Dame News 500 Grace Hall Notre Dame, IN 46556 USA Facebook Twitter Instagram YouTube Pinterest © 2022 University of Notre Dame Search Mobile App News Events Visit Accessibility Facebook Twitter Instagram YouTube LinkedIn